New study tests simple strategies to keep HIV patients on track

NCT ID NCT05040841

Completed Disease control Sponsor: Boston University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 07, 2026 · Updated 3 times

Summary

This study tests different ways to help people with HIV take their medication regularly. Researchers will enroll 534 people starting HIV treatment in Cape Town. They will use a device to track pill-taking and try different outreach methods, like calls or texts, to support adherence. The goal is to see which strategies help more people achieve undetectable virus levels.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioural intervention (outreach calls, texts, and adherence support)
What this could lead to: If successful, this could show which simple, low-cost strategies best help people stay on HIV treatment and keep the virus under control.
What could go wrong: This is a behavioral study, not a drug trial, so it won't cure HIV. Results may vary by clinic and may not apply to all settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHERENCE, MEDICATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease Medication Adherence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADHERENCE, MEDICATION HIV INFECTIONS

Contacts and locations

Locations

Mzamomhle

Cape Town, Western Cape, South Africa
Phumlani

Cape Town, Western Cape, South Africa
Weltevreden Valley

Cape Town, Western Cape, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.